Your browser doesn't support javascript.
loading
Simplified Oligonucleotide Phosphorus Deprotection Process with Reduced 3-(2-Cyanoethyl) Thymidine Impurities.
Zhou, Xuan; Shi, Xianglin; Fillon, Yannick; Antia, Firoz; Pickel, Thomas; Yang, Jing; Zhang, William; Delavari, Armin; Zhang, Jiabao.
Afiliação
  • Zhou X; Oligonucleotide Process Development, Biogen, Cambridge, Massachusetts, USA.
  • Shi X; Leal Therapeutics, Worcester, Massachusetts, USA.
  • Fillon Y; Oligonucleotide Process Development, Biogen, Cambridge, Massachusetts, USA.
  • Antia F; Oligonucleotide Process Development, Biogen, Cambridge, Massachusetts, USA.
  • Pickel T; Oligonucleotide Process Development, Biogen, Cambridge, Massachusetts, USA.
  • Yang J; Intellia Therapeutics, Inc., Cambridge, Massachusetts, USA.
  • Zhang W; Oligonucleotide Process Development, Biogen, Cambridge, Massachusetts, USA.
  • Delavari A; Oligonucleotide Process Development, Biogen, Cambridge, Massachusetts, USA.
  • Zhang J; Oligonucleotide Process Development, Biogen, Cambridge, Massachusetts, USA.
Nucleic Acid Ther ; 34(2): 83-89, 2024 04.
Article em En | MEDLINE | ID: mdl-38315742
ABSTRACT
Oligonucleotides have emerged as valuable new therapeutics. Presently, oligonucleotide manufacturing consists in a series of stepwise additions until the full-length product is obtained. Deprotection of the phosphorus backbone before cleavage and deprotection (C&D) by ammonolysis is necessary to control the 3-(2-cyanoethyl) thymidine (CNET) impurity. In this study, we demonstrate that the use of piperazine as a scavenger of acrylonitrile allows phosphorus deprotection and C&D to be combined in a single step. This reduces solvent consumption, processing time, and CNET levels. Additionally, we showed that substitution of piperazine for triethylamine in the phosphorus deprotection step of supported-synthesis leads to reduced reaction times and lower levels of CNET impurities.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligonucleotídeos / Fósforo Idioma: En Revista: Nucleic Acid Ther Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligonucleotídeos / Fósforo Idioma: En Revista: Nucleic Acid Ther Ano de publicação: 2024 Tipo de documento: Article